| Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study KM Sink, X Leng, J Williamson, SB Kritchevsky, K Yaffe, L Kuller, S Yasar, ... Archives of internal medicine 169 (13), 1195-1202, 2009 | 285 | 2009 |
| Effects of endocannabinoid system modulation on cognitive and emotional behavior C Zanettini, LV Panlilio, M Aliczki, SR Goldberg, J Haller, S Yasar Frontiers in behavioral neuroscience 5, 57, 2011 | 262 | 2011 |
| Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study S Yasar, J Xia, W Yao, CD Furberg, QL Xue, CI Mercado, AL Fitzpatrick, ... Neurology 81 (10), 896-903, 2013 | 232 | 2013 |
| Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II MM Mielke, VVR Bandaru, NJ Haughey, J Xia, LP Fried, S Yasar, M Albert, ... Neurology 79 (7), 633-641, 2012 | 219 | 2012 |
| Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women YJ Cao, DE Mager, EM Simonsick, SN Hilmer, SM Ling, BG Windham, ... Clinical Pharmacology & Therapeutics 83 (3), 422-429, 2008 | 212 | 2008 |
| Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors M Melis, G Pillolla, A Luchicchi, AL Muntoni, S Yasar, SR Goldberg, ... Journal of Neuroscience 28 (51), 13985-13994, 2008 | 201 | 2008 |
| Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers DM Harvey, S Yasar, SJ Heishman, LV Panlilio, JE Henningfield, ... Psychopharmacology 175, 134-142, 2004 | 183 | 2004 |
| Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats J Haller, I Barna, B Barsvari, K Gyimesi Pelczer, S Yasar, LV Panlilio, ... Psychopharmacology 204, 607-616, 2009 | 182 | 2009 |
| The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition M Scherma, J Medalie, W Fratta, SK Vadivel, A Makriyannis, D Piomelli, ... Neuropharmacology 54 (1), 129-140, 2008 | 177 | 2008 |
| Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates Z Justinova, RA Mangieri, M Bortolato, SI Chefer, AG Mukhin, JR Clapper, ... Biological psychiatry 64 (11), 930-937, 2008 | 172 | 2008 |
| Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-α nuclear receptors C Mazzola, J Medalie, M Scherma, LV Panlilio, M Solinas, G Tanda, ... Learning & memory 16 (5), 332-337, 2009 | 167 | 2009 |
| Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study K Bettermann, AM Arnold, J Williamson, S Rapp, K Sink, JF Toole, ... Journal of Stroke and Cerebrovascular Diseases 21 (6), 436-444, 2012 | 166 | 2012 |
| Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats M Solinas, LV Panlilio, Z Justinova, S Yasar, SR Goldberg Nature protocols 1 (3), 1194-1206, 2006 | 155 | 2006 |
| Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors P Mascia, M Pistis, Z Justinova, LV Panlilio, A Luchicchi, S Lecca, ... Biological psychiatry 69 (7), 633-641, 2011 | 135 | 2011 |
| Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging S Yasar, M Corrada, R Brookmeyer, C Kawas Neurobiology of aging 26 (2), 157-163, 2005 | 133 | 2005 |
| An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease KM Jung, G Astarita, S Yasar, V Vasilevko, DH Cribbs, E Head, ... Neurobiology of aging 33 (8), 1522-1532, 2012 | 132 | 2012 |
| Albuminuria and dementia in the elderly: a community study JI Barzilay, AL Fitzpatrick, J Luchsinger, S Yasar, C Bernick, NS Jenny, ... American journal of kidney diseases 52 (2), 216-226, 2008 | 129 | 2008 |
| Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3′-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats M Scherma, LV Panlilio, P Fadda, L Fattore, I Gamaleddin, B Le Foll, ... Journal of Pharmacology and Experimental Therapeutics 327 (2), 482-490, 2008 | 127 | 2008 |
| Endocannabinoid system involvement in brain reward processes related to drug abuse M Solinas, S Yasar, SR Goldberg Pharmacological research 56 (5), 393-405, 2007 | 120 | 2007 |
| The endogenous cannabinoid anandamide produces Δ-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide … M Solinas, G Tanda, Z Justinova, CE Wertheim, S Yasar, D Piomelli, ... Journal of Pharmacology and Experimental Therapeutics 321 (1), 370-380, 2007 | 119 | 2007 |
